Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years

Circulation

Volumn 115, Issue 19, 2007, Pages 2474-2480

  Kleemann, Thomas ^a   Becker, Torsten ^a   Doenges, Klaus ^a   Vater, Margit ^a   Senges, Jochen ^a   Schneider, Steffen ^a   Saggau, Werner ^a   Weisse, Udo ^a   Seidl, Karlheinz ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Cardioverter defibrillators, implantable; Defibrillation; Tachyarrhythmia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 34248579318     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.663807     Document Type: Article

References (28)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
2. Moss AJ, Hall J, David S, Cannom DS, James P, Dauber JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber M, Brown MW, Moonsenong H. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
4. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G; for the Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiological testing to identify patients with coronary artery disease who are at risk for sudden death. N Eng J Med. 2000;342:1937-1945.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
6. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoracotomy defibrillation systems. J Am Coll Cardiol. 1995;25:776-786.
7. Lawton JS, Ellenbogen KA, Wood MA, Stambler BS, Herre JM, Nath S, Bernstein RC, Di Marco JP, Haines DE, Szentpetery S, Baker LD, Damiano RJ Jr. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol. 1996;78:647-651.
8. Helguera ME, Maloney JD, Pinski SJ, Woscoboinik JR, Wilkoff BL, Castle LW. Long-term performance of endocardial pacing leads. Pacing Clin Electrophysiol. 1994;17:56-64.
9. Mehta D, Nayak HM, Singson M, Chao S, Pe E, Camunas JL, Gomes JA. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol. 1998;21:1893-1900.
10. Schwacke H, Drögemüller A, Siemon G, Werling C, Saggau W, Senges J, Seidl K. Lead-related complications in 340 patients with an implantable cardioverter/defibrillator. Z Kardiol. 1999;88:559-565.
11. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
12. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38-43.
13. Medtronic Inc. Defibrillation leads reference. CRM Product Performance Report 2006. Available at: http://www.medtronic.com/crm/performance/references/ defib_lead_reference.html. Accessed August 30, 2006.
14. St. Jude product performance report, April 2006. Available at: http://www.sjm.com/devices/deviceindex.aspx. Accessed August 30, 2006.
15. Kitamura S, Kazuhiro S, Takahashi K, Wataru S, Kazuhiro S, Naohiko A, Kazuo N, Junjiro K, Shiro K. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J. 2006;70:273-277.
16. Hauser RG, Cannom D, Hayes DL, Parsonnet V, Hayes J, Ratliff N, Tyers GF, Epstein AE, Vlay SC, Furman S, Gross J. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2002;25:879-882.
17. Hayes DL, Graham KJ, Irwin M, Vidaillet H, Disler G, Sweesy M, Kincaid D, Osborn MJ, Suman VJ, Neubauer SA. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol. 1995;18:999-1004.
18. Antonelli D, Rosenfeld T, Freeberg NA, Palma E, Gross JN, Furman S. Insulation lead malfunction: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electropyhsiol. 1998;21:418-421.
19. Mond HG. Engineering and clinical aspects of pacing leads. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing and Defibrillation. Philadelphia, Pa: WB Saunders Co; 2000:127-150.
20. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO, Chugh SS, Rea RF, Hayes DL, Hammill SC, Friedman PA. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901-904.
21. Mewis C, Kühlkamp V, Dörnberger V, Mermi J, Seipel L. High incidence of isolator fractures in transvenous implanted cardioverter/ defibrillators. Z Kardiol. 1997;86:85-94.
22. De Lurgio DB, Sathavorn C, Mera F, Leon A, Walter PF, Langberg JJ. Incidence and complications of abrasion of implantable cardioverter- defibrillator leads. Am J Cardiol. 1997;79:1409-1411.
23. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN. Subclavian crush syndrome complication transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol. 1995;18:973-979.
24. Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q. Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators Trial. Am Heart J. 2001;141:92-98.
25. Takahashi T, Bhandari AK, Watanuki M, Cannom DS, Sakurada H, Hiraoka M. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J. 2002;66:746-750.
26. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 2005;14:71-78.
27. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol. 2002;39:1323-1328.
28. Burke MC, Coman JA, Cates AW, Lindstrom CC, Sandler DA, Kim SS, Knight BP. Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: implications for a total subcutaneous implantable defibrillator. Heart Rhythm. 2005;2:1332-1338.